154 related articles for article (PubMed ID: 20345326)
1. Electrospraying, spray drying and related techniques for production and formulation of drug nanoparticles.
Peltonen L; Valo H; Kolakovic R; Laaksonen T; Hirvonen J
Expert Opin Drug Deliv; 2010 Jun; 7(6):705-19. PubMed ID: 20345326
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of spray-dried tobramycin powders containing nanoparticles for pulmonary delivery.
Pilcer G; Vanderbist F; Amighi K
Int J Pharm; 2009 Jan; 365(1-2):162-9. PubMed ID: 18782609
[TBL] [Abstract][Full Text] [Related]
3. The effect of operating and formulation variables on the morphology of spray-dried protein particles.
Maa YF; Costantino HR; Nguyen PA; Hsu CC
Pharm Dev Technol; 1997 Aug; 2(3):213-23. PubMed ID: 9552449
[TBL] [Abstract][Full Text] [Related]
4. Biodegradable nanoparticle flocculates for dry powder aerosol formulation.
Shi L; Plumley CJ; Berkland C
Langmuir; 2007 Oct; 23(22):10897-901. PubMed ID: 17894513
[TBL] [Abstract][Full Text] [Related]
5. Redispersible drug nanoparticles prepared without dispersant by electro-spray drying.
Ho H; Lee J
Drug Dev Ind Pharm; 2012 Jun; 38(6):744-51. PubMed ID: 22010908
[TBL] [Abstract][Full Text] [Related]
6. Spray-dried microparticles containing polymeric nanocapsules: formulation aspects, liquid phase interactions and particles characteristics.
Tewa-Tagne P; Briançon S; Fessi H
Int J Pharm; 2006 Nov; 325(1-2):63-74. PubMed ID: 16872767
[TBL] [Abstract][Full Text] [Related]
7. Conformational analysis of protein secondary structure during spray-drying of antibody/mannitol formulations.
Schüle S; Friess W; Bechtold-Peters K; Garidel P
Eur J Pharm Biopharm; 2007 Jan; 65(1):1-9. PubMed ID: 17034996
[TBL] [Abstract][Full Text] [Related]
8. Preparation of dry powder dispersions for non-viral gene delivery by freeze-drying and spray-drying.
Seville PC; Kellaway IW; Birchall JC
J Gene Med; 2002; 4(4):428-37. PubMed ID: 12124985
[TBL] [Abstract][Full Text] [Related]
9. Preparation of zolmitriptan-chitosan microparticles by spray drying for nasal delivery.
Alhalaweh A; Andersson S; Velaga SP
Eur J Pharm Sci; 2009 Oct; 38(3):206-14. PubMed ID: 19616094
[TBL] [Abstract][Full Text] [Related]
10. Dry powder aerosol delivery of large hollow nanoparticulate aggregates as prospective carriers of nanoparticulate drugs: effects of phospholipids.
Hadinoto K; Phanapavudhikul P; Kewu Z; Tan RB
Int J Pharm; 2007 Mar; 333(1-2):187-98. PubMed ID: 17084567
[TBL] [Abstract][Full Text] [Related]
11. Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles.
Azarmi S; Tao X; Chen H; Wang Z; Finlay WH; Löbenberg R; Roa WH
Int J Pharm; 2006 Aug; 319(1-2):155-61. PubMed ID: 16713150
[TBL] [Abstract][Full Text] [Related]
12. The effect of vehicle on physical properties and aerosolisation behaviour of disodium cromoglycate microparticles spray dried alone or with L-leucine.
Najafabadi AR; Gilani K; Barghi M; Rafiee-Tehrani M
Int J Pharm; 2004 Nov; 285(1-2):97-108. PubMed ID: 15488683
[TBL] [Abstract][Full Text] [Related]
13. Production methods for nanodrug particles using the bottom-up approach.
Chan HK; Kwok PC
Adv Drug Deliv Rev; 2011 May; 63(6):406-16. PubMed ID: 21457742
[TBL] [Abstract][Full Text] [Related]
14. Formulation parameters of crystalline nanosuspensions on spray drying processing: a DoE approach.
Kumar S; Xu X; Gokhale R; Burgess DJ
Int J Pharm; 2014 Apr; 464(1-2):34-45. PubMed ID: 24447788
[TBL] [Abstract][Full Text] [Related]
15. Insulin-micro- and nanoparticles for pulmonary delivery.
Klingler C; Müller BW; Steckel H
Int J Pharm; 2009 Jul; 377(1-2):173-9. PubMed ID: 19446621
[TBL] [Abstract][Full Text] [Related]
16. Stabilizing formulations for inhalable powders of an adenovirus 35-vectored tuberculosis (TB) vaccine (AERAS-402).
Jin TH; Tsao E; Goudsmit J; Dheenadhayalan V; Sadoff J
Vaccine; 2010 Jun; 28(27):4369-75. PubMed ID: 20444437
[TBL] [Abstract][Full Text] [Related]
17. Influences of process and formulation parameters on powder flow properties and immunogenicity of spray dried polymer particles entrapping recombinant pneumococcal surface protein A.
Anish C; Upadhyay AK; Sehgal D; Panda AK
Int J Pharm; 2014 May; 466(1-2):198-210. PubMed ID: 24631054
[TBL] [Abstract][Full Text] [Related]
18. Correlations between cascade impactor analysis and laser diffraction techniques for the determination of the particle size of aerosolised powder formulations.
Pilcer G; Vanderbist F; Amighi K
Int J Pharm; 2008 Jun; 358(1-2):75-81. PubMed ID: 18359587
[TBL] [Abstract][Full Text] [Related]
19. Quality by Design approach to spray drying processing of crystalline nanosuspensions.
Kumar S; Gokhale R; Burgess DJ
Int J Pharm; 2014 Apr; 464(1-2):234-42. PubMed ID: 24412337
[TBL] [Abstract][Full Text] [Related]
20. Spray freeze drying to produce a stable Delta(9)-tetrahydrocannabinol containing inulin-based solid dispersion powder suitable for inhalation.
van Drooge DJ; Hinrichs WL; Dickhoff BH; Elli MN; Visser MR; Zijlstra GS; Frijlink HW
Eur J Pharm Sci; 2005 Oct; 26(2):231-40. PubMed ID: 16084699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
